Might Might - Cambridge Rare Disease Summit 2015
-
Upload
cambridge-rare-disease-network -
Category
Health & Medicine
-
view
134 -
download
2
Transcript of Might Might - Cambridge Rare Disease Summit 2015
![Page 1: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/1.jpg)
Matthew Might, Ph.D. Associate Professor University of Utah
Visiting Assoc. Professor Harvard Medical School
Treating the Rarest of Diseases What do you do when you’re one of a kind?
President NGLY1.org
![Page 2: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/2.jpg)
a story
![Page 3: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/3.jpg)
Bertrand
![Page 4: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/4.jpg)
Bertrand Russell
![Page 5: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/5.jpg)
![Page 6: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/6.jpg)
NGLY1
![Page 7: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/7.jpg)
![Page 8: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/8.jpg)
an odyssey
![Page 9: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/9.jpg)
“undiagnosed island”
![Page 10: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/10.jpg)
![Page 11: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/11.jpg)
![Page 12: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/12.jpg)
![Page 13: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/13.jpg)
![Page 14: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/14.jpg)
![Page 15: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/15.jpg)
![Page 16: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/16.jpg)
![Page 17: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/17.jpg)
![Page 18: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/18.jpg)
![Page 19: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/19.jpg)
![Page 20: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/20.jpg)
![Page 21: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/21.jpg)
![Page 22: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/22.jpg)
![Page 23: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/23.jpg)
![Page 24: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/24.jpg)
David Goldstein Vandana ShashiKelly Schoch
![Page 25: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/25.jpg)
![Page 26: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/26.jpg)
{NGLY1
![Page 27: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/27.jpg)
{NGLY1
![Page 28: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/28.jpg)
“first”
![Page 29: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/29.jpg)
“only”
![Page 30: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/30.jpg)
![Page 31: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/31.jpg)
![Page 32: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/32.jpg)
![Page 33: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/33.jpg)
![Page 34: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/34.jpg)
![Page 35: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/35.jpg)
![Page 36: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/36.jpg)
![Page 37: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/37.jpg)
![Page 38: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/38.jpg)
![Page 39: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/39.jpg)
![Page 40: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/40.jpg)
![Page 41: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/41.jpg)
Hudson Freeze (Sanford-Burnham-Prebys)
![Page 42: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/42.jpg)
“You got it.”
![Page 43: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/43.jpg)
“not actionable”
![Page 44: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/44.jpg)
![Page 45: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/45.jpg)
NGLY1
![Page 46: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/46.jpg)
![Page 47: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/47.jpg)
Science becomes medicine.
![Page 48: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/48.jpg)
Science becomes action.
![Page 49: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/49.jpg)
![Page 50: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/50.jpg)
![Page 51: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/51.jpg)
![Page 52: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/52.jpg)
We can’t do this alone.
![Page 53: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/53.jpg)
I wrote a blog post.
![Page 54: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/54.jpg)
1. Go viral
![Page 55: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/55.jpg)
2. Rank high
![Page 56: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/56.jpg)
![Page 57: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/57.jpg)
![Page 58: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/58.jpg)
![Page 59: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/59.jpg)
![Page 60: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/60.jpg)
![Page 61: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/61.jpg)
3898
![Page 62: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/62.jpg)
Meetings
![Page 63: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/63.jpg)
![Page 64: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/64.jpg)
Foundations
![Page 65: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/65.jpg)
![Page 66: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/66.jpg)
Natural experiments
![Page 67: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/67.jpg)
![Page 68: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/68.jpg)
CDG Natural History
![Page 69: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/69.jpg)
![Page 70: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/70.jpg)
![Page 71: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/71.jpg)
![Page 72: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/72.jpg)
![Page 73: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/73.jpg)
![Page 74: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/74.jpg)
![Page 75: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/75.jpg)
![Page 76: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/76.jpg)
![Page 77: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/77.jpg)
![Page 78: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/78.jpg)
![Page 79: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/79.jpg)
![Page 80: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/80.jpg)
![Page 81: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/81.jpg)
![Page 82: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/82.jpg)
![Page 83: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/83.jpg)
![Page 84: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/84.jpg)
![Page 85: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/85.jpg)
![Page 86: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/86.jpg)
![Page 87: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/87.jpg)
![Page 88: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/88.jpg)
![Page 89: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/89.jpg)
![Page 90: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/90.jpg)
![Page 91: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/91.jpg)
![Page 92: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/92.jpg)
![Page 93: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/93.jpg)
![Page 94: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/94.jpg)
![Page 95: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/95.jpg)
![Page 96: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/96.jpg)
![Page 97: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/97.jpg)
![Page 98: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/98.jpg)
![Page 99: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/99.jpg)
![Page 100: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/100.jpg)
![Page 101: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/101.jpg)
![Page 102: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/102.jpg)
![Page 103: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/103.jpg)
![Page 104: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/104.jpg)
![Page 105: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/105.jpg)
![Page 106: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/106.jpg)
![Page 107: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/107.jpg)
![Page 108: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/108.jpg)
![Page 109: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/109.jpg)
![Page 110: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/110.jpg)
![Page 111: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/111.jpg)
![Page 112: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/112.jpg)
![Page 113: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/113.jpg)
![Page 114: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/114.jpg)
![Page 115: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/115.jpg)
![Page 116: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/116.jpg)
![Page 117: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/117.jpg)
![Page 118: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/118.jpg)
![Page 119: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/119.jpg)
![Page 120: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/120.jpg)
Biomarkers!
![Page 121: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/121.jpg)
Hypoglycosylation!
![Page 122: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/122.jpg)
Assays
![Page 123: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/123.jpg)
Source: Hudson Freeze
![Page 124: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/124.jpg)
![Page 125: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/125.jpg)
Model organisms
![Page 126: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/126.jpg)
![Page 127: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/127.jpg)
![Page 128: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/128.jpg)
![Page 129: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/129.jpg)
![Page 130: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/130.jpg)
![Page 131: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/131.jpg)
Enzyme replacement
![Page 132: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/132.jpg)
![Page 133: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/133.jpg)
![Page 134: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/134.jpg)
![Page 135: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/135.jpg)
PEG polymer TAT peptide
![Page 136: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/136.jpg)
Crowd science
![Page 137: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/137.jpg)
Su Lab @ Scripps
![Page 138: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/138.jpg)
mark2cure.org
![Page 139: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/139.jpg)
![Page 140: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/140.jpg)
Repurposing
![Page 141: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/141.jpg)
![Page 142: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/142.jpg)
Tufts CSSD
£1,600,000,000
![Page 143: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/143.jpg)
£1,600,000,0007000 ×
![Page 144: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/144.jpg)
£12,000,000,000,000
![Page 145: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/145.jpg)
Repurposing is key
![Page 146: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/146.jpg)
![Page 147: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/147.jpg)
![Page 148: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/148.jpg)
patient drug
![Page 149: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/149.jpg)
![Page 150: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/150.jpg)
Basic science
![Page 151: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/151.jpg)
Endo-β-N-acetylglucosaminidase forms N-GlcNAcprotein aggregates during ER-associated degradationin Ngly1-defective cellsChengcheng Huanga,b, Yoichiro Haradaa, Akira Hosomia, Yuki Masahara-Negishia, Junichi Seinoa, Haruhiko Fujihiraa,Yoko Funakoshia, Takehiro Suzukic, Naoshi Dohmaec, and Tadashi Suzukia,b,1
aGlycometabolome Team, Systems Glycobiology Research Group, RIKEN–Max Planck Joint Research Center for Systems Chemical Biology, RIKEN GlobalResearch Cluster, Wako, Saitama 351-0198, Japan; bGraduate School of Science and Engineering, Saitama University, Saitama, Saitama 338-8570, Japan;and cCollaboration Promotion Unit, RIKEN Global Research Cluster, Wako, Saitama 351-0198, Japan
Edited by David W. Russell, University of Texas Southwestern Medical Center, Dallas, TX, and approved December 30, 2014 (received for reviewAugust 1, 2014)
The cytoplasmic peptide:N-glycanase (PNGase; Ngly1 in mice) isa deglycosylating enzyme involved in the endoplasmic reticulum(ER)-associated degradation (ERAD) process. The precise role ofNgly1 in the ERAD process, however, remains unclear in mammals.The findings reported herein, using mouse embryonic fibroblast(MEF) cells, that the ablation of Ngly1 causes dysregulation of theERAD process. Interestingly, not only delayed degradation but alsothe deglycosylation of a misfolded glycoprotein was observed inNgly1−/− MEF cells. The unconventional deglycosylation reactionwas found to be catalyzed by the cytosolic endo-β-N-acetylgluco-saminidase (ENGase), generating aggregation-prone N-GlcNAc pro-teins. The ERAD dysregulation in cells lacking Ngly1 was restoredby the additional knockout of ENGase gene. Thus, our study under-scores the functional importance of Ngly1 in the ERAD process andprovides a potential mechanism underlying the phenotypic conse-quences of a newly emerging genetic disorder caused by mutationof the human NGLY1 gene.
PNGase (Ngly1) | ENGase | protein aggregates | glycoprotein | ERAD
Endoplasmic reticulum (ER)-associated degradation (ERAD)constitutes one of the quality control mechanisms for newly
synthesized proteins in the ER. The ERAD process involvesa series of events, including aberrant domain recognition, ubiq-uitination, translocation from the ER to the cytosol, and deg-radation by proteasomes. Numerous lines of evidence point tothe existence of an ERAD system dedicated to N-linked glyco-proteins; in this system, specific N-glycan structures dictate thefolding status of client glycoproteins (1, 2). Once glycoproteins inthe ER lumen are targeted for degradation, they are retro-translocated into the cytosol, where the 26S proteasome playsa central role in their degradation (3). During the degradationprocess, N-glycans are removed by the action of the cytoplasmicpeptide:N-glycanase (PNGase) (4–6).Activity of the cytoplasmic PNGase was first described in mam-
malian cells (7, 8), and the gene encoding cytoplasmic PNGase(PNG1 in yeast; Ngly1/NGLY1 in mice/human) is widely dis-tributed throughout eukaryotes (9). The functional importanceof cytoplasmic PNGase in the ERAD process is evident in yeast(10–13). On the other hand, the suppression of Ngly1 gene ex-pression by siRNA in mammalian cells resulted in a reduceddeglycosylation of T-cell receptor α subunit (TCRα) or MHC classI heavy chain, whereas no significant delay in their degradationwas observed (14, 15). Moreover, Z-VAD-fmk, a pan-caspase in-hibitor, was shown to inhibit cytoplasmic PNGase activity in vivo,but it did not impede the degradation of MHC class I heavy chain(16). Consequently, the functional importance of the cytoplasmicPNGase remains elusive in mammalian cells.PNGase-mediated deglycosylation generates free oligosaccharides
in the cytosol (17). Recent evidence suggests that a nonlysosomaldegradation pathway exists for these cytosolic free glycans (17).
This degradation process involves cytosolic endo-β-N-acetylglu-cosaminidase (ENGase) (18, 19). Although the ENGase is believedto be involved in the catabolism of cytosolic free oligosaccharides,recent evidence shows that it can deglycosylate glycoproteins in vivoto generate N-GlcNAc–bearing proteins in Arabidopsis thaliana(20), raising the possibility that this enzyme may also act as adeglycosylation enzyme for misfolded glycoproteins in the cytosol(21, 22) (Fig. 1A).Recently, patients harboring mutations on the NGLY1 gene, an
ortholog of the cytoplasmic PNGase in mammalian cells (23), havebeen described (24, 25). Although this observation emphasizes thefunctional importance of this protein in mammalian cells, mecha-nistic insight into the phenotypic consequences of these patientsremains unclarified. In this study, we established an ERAD modelsubstrate, RTAΔm, and demonstrated that the delay in its degra-dation was evident in Ngly1−/− mouse embryonic fibroblast (MEF)cells. Interestingly, the delay was canceled by additional geneknockout of ENGase. The degradation of RTAΔm in double-knockout cells remains proteasome-dependent, clearly indicatingthat the presence of an N-glycan on RTAΔm did not affect theefficiency of proteasomal degradation. Moreover, the occurrenceof N-GlcNAc–modified RTAΔm in Ngly1−/− MEF cells was iden-tified by MS analysis, demonstrating that the ENGase-mediated
Significance
In the endoplasmic reticulum (ER), N-glycans on glycoproteinsplay important roles in dictating the folding status of proteinsby a sophisticated N-glycan–dependent protein quality controlmachinery. In this study we identified the dysregulation of ER-associated degradation (ERAD) in cells that were defective inthe cytosolic deglycosylating enzyme, Ngly1. ERAD dysregula-tion was caused by an unexpected deglycosylating activity ofendo-β-N-acetylglucosaminidase, another cytosolic deglycosy-lation enzyme, and this action resulted in the intracellularformation of protein aggregates. Our results clearly point tothe critical role of N-glycans even in cytosolic events of theERAD process by controlling the conformation/solubility ofproteins. This study may also provide a potential mechanismfor explaining the pathology of a human genetic disordercaused by mutations in the NGLY1 gene.
Author contributions: C.H. and Tadashi Suzuki designed research; C.H., Y.H., A.H., Y.M.-N.,J.S., H.F., Y.F., Takehiro Suzuki, and N.D. performed research; Y.H., A.H., Y.M.-N., and Y.F.contributed new reagents/analytic tools; C.H., Y.H., A.H., J.S., H.F., Y.F., Takehiro Suzuki,N.D., and Tadashi Suzuki analyzed data; and C.H. and Tadashi Suzuki wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.1To whom correspondence should be addressed. Email: [email protected].
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1414593112/-/DCSupplemental.
1398–1403 | PNAS | February 3, 2015 | vol. 112 | no. 5 www.pnas.org/cgi/doi/10.1073/pnas.1414593112
![Page 152: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/152.jpg)
![Page 153: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/153.jpg)
![Page 154: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/154.jpg)
![Page 155: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/155.jpg)
![Page 156: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/156.jpg)
![Page 157: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/157.jpg)
![Page 158: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/158.jpg)
![Page 159: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/159.jpg)
![Page 160: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/160.jpg)
Patient-led science
![Page 161: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/161.jpg)
computer science
![Page 162: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/162.jpg)
computer science
biology & medicine
![Page 163: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/163.jpg)
A drug discovery platform for NGLY1 deficiency
![Page 164: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/164.jpg)
![Page 165: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/165.jpg)
![Page 166: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/166.jpg)
![Page 167: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/167.jpg)
YesReplicable?
![Page 169: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/169.jpg)
![Page 170: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/170.jpg)
Advocacy & Outreach
![Page 171: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/171.jpg)
![Page 172: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/172.jpg)
![Page 173: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/173.jpg)
![Page 174: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/174.jpg)
Parting thought
![Page 175: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/175.jpg)
“not actionable”
![Page 176: Might Might - Cambridge Rare Disease Summit 2015](https://reader038.fdocuments.net/reader038/viewer/2022110108/58edd1f31a28ab45118b46bd/html5/thumbnails/176.jpg)
Thank you. http://matt.might.net/ [email protected] @mattmight